Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controlsResearch in context

Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controlsResearch in context

Summary: Background: An ongoing important need exists to rapidly develop novel therapeutics for COVID-19 that will retain antiviral efficacy in the setting of rapidly evolving SARS-CoV-2 variants and potential future development of resistance of SARS-COV-2 to remdesivir and protease inhibitors. To...

Full description

Bibliographic Details
Main Authors: Keren Chen, Nicholas J. Jackson, Theodoros Kelesidis
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:EBioMedicine
Subjects:
Mitochondrial antioxidants
SARS-CoV-2 infection
Antiviral treatment
COVID-19
Translational research
Post-exposure prophylaxis
Online Access:http://www.sciencedirect.com/science/article/pii/S235239642400077X

Internet

http://www.sciencedirect.com/science/article/pii/S235239642400077X

Similar Items